2027 Accounting & Finance Development Program

About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube.

Accounting & Finance Development Program Description: AbbVie’s Accounting & Finance Development Program (AFDP) offers rotational experiences to prepare you for accounting and financial management roles. The roles are crafted to help you develop exceptional functional and leadership traits by working on a wide range of projects, while providing exposure to different leaders in the company. These accounting and finance experiences will develop you and put you on the fast track to future accounting and finance leadership opportunities at AbbVie. AbbVie AFDP rotations are structured within four functional areas of the business: Commercial: Commercial Finance provides global leadership, guidance, and financial support to AbbVie’s Commercial operations, including the Allergan Aesthetics business. This organization forecasts for our key brands in Immunology, Oncology, or Neuroscience and Eye Care. Commercial International Therapeutics helps to support our global operations and planning worldwide. Operations: Operations Finance provides leadership and guidance to Manufacturing, Supply Chain, Purchasing and various other support functions related to financial planning and internal management reporting. The Finance team provides decision support services through analysis of key financial information, while driving operating margin improvement, maximizing tax advantaged product sourcing, and maintaining an assurance of supply. Research & Development: Supports AbbVie’s Research & Development (R&D) activities with primary focus on pipeline compounds in development, beginning from target and molecule discovery to human clinical study conduct to filing for regulatory approvals in markets around the world, and support of on-market products for new indications and regulatory commitments. R&D Finance is generally aligned around the stages of compound development and its related operating functions. Corporate: Accounting: The Accounting COE governs AbbVie’s global accounting function, establishing and monitoring global policy, procedures, and controls for One AbbVie. Financial Planning and Analysis (FP&A): FP&A drives business performance by serving as trusted advisors and partners who influence strategy, enable operation excellence, and maintain a strong controls environment. Finance Shared Services: Finance Shared Services governs and supports AbbVie’s global, standardized, end-to-end, back-office processes, maintaining the operations and transactional business activities that enable the company to run. Internal Audit: Internal Audit protects and enhances organizational value by providing risk-based and objective assurance, advice, and insight. Investor Relations: The Investor Relations (IR) function is responsible for developing, implementing, and managing a comprehensive, strategic, and proactive investor relations program that optimizes the value of AbbVie’s stock. IR serves as a primary point of interface to introduce, position, and market the company to equity analysts and large institutional investors. IR disseminates key company information regarding AbbVie’s corporate strategy, financial performance, and product/pipeline performance to assist investors in making informed investment decisions. The IR team works closely with numerous functions within the company, including the Executive Leadership Team, Finance,